Evidence map›Paper›PMID 29891673›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Structure and mutagenic analysis of the lipid II flippase MurJ from

Sanduo Zheng, Lok-To Sham, Frederick A Rubino, Kelly P Brock, William P Robins, John J Mekalanos, Debora S Marks, Thomas G Bernhardt, Andrew C Kruse

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Phage lysis protein LysScience advances · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Targeting Essential Hypothetical Proteins ofBioMed research international · 2023
    Article
  20. Lipid Transport Across Bacterial Membranes.Annual review of cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Sanduo ZhengDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Lok-To ShamDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
Frederick A RubinoDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138.
Kelly P BrockDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115.
William P RobinsDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
John J MekalanosDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
Debora S MarksDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138.
Thomas G BernhardtDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
Andrew C KruseDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115; andrew_kruse@hms.harvard.edu.ORCID 0000-0002-1467-1222
Harvard University · US

Funding

Targeting bacterial cell wall biogenesis for the development of novel antimicrobU19AI109764 · NIAID · HARVARD MEDICAL SCHOOL · PI KASPER, DENNIS L. · 2014 to 2018
$25.2M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Studies Toward Hybrid Glycopeptide AntibioticsR01GM066174 · NIGMS · PRINCETON UNIVERSITY · PI KAHNE, DANIEL · 2002 to 2018
$8.9M
Peptidoglycan Biogenesis in Escherichia ColiR01AI083365 · NIAID · HARVARD MEDICAL SCHOOL · PI Thomas G Bernhardt · 2010 to 2026
$8.3M
Genetic Analysis of Toxinogenesis in Vibrio CholeraeR01AI018045 · NIAID · HARVARD MEDICAL SCHOOL · PI MEKALANOS, JOHN JOSEPH · 2009 to 2018
$6.7M
Mechanism and Inhibition of Enzymes that Assemble Bacterial Cell WallR01GM076710 · NIGMS · HARVARD MEDICAL SCHOOL · PI WALKER, SUZANNE · 2007 to 2019
$5.9M
Accelerated Determination of 3D Structures of Proteins and ComplexesR01GM106303 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI SANDER, CHRIS · 2013 to 2016
$1.7M
NIAID NIH HHS R01 AI018045NIAID NIH HHS R01 AI083365NIAID NIH HHS T32 AI007061NIAID NIH HHS U19 AI109764NIGMS NIH HHS R01 GM066174NIGMS NIH HHS R01 GM076710NIGMS NIH HHS R01 GM106303
6 · The paper itself

Abstract

The peptidoglycan cell wall provides an essential protective barrier in almost all bacteria, defining cellular morphology and conferring resistance to osmotic stress and other environmental hazards. The precursor to peptidoglycan, lipid II, is assembled on the inner leaflet of the plasma membrane. However, peptidoglycan polymerization occurs on the outer face of the plasma membrane, and lipid II must be flipped across the membrane by the MurJ protein before its use in peptidoglycan synthesis. Due to its central role in cell wall assembly, MurJ is of fundamental importance in microbial cell biology and is a prime target for novel antibiotic development. However, relatively little is known regarding the mechanisms of MurJ function, and structural data for MurJ are available only from the extremophile

Indexed as

Crystallography, X-RayEscherichia coli ProteinsEvolution, MolecularGene LibraryGram-Negative Anaerobic Straight, Curved, and Helical RodsHigh-Throughput Nucleotide SequencingModels, MolecularMutationPhospholipid Transfer ProteinsProtein ConformationRecombinant Fusion ProteinsStructure-Activity RelationshipEscherichia coli ProteinsMurJ protein, E coliPhospholipid Transfer ProteinsRecombinant Fusion Proteinslipid flippasepeptidoglycanX-ray crystallography

Identifiers

PMID29891673
PMCPMC6042122
OpenAlexW2951041301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.